Cognetivity Neurosciences Ltd. (CGNSF)

USD 0.0

(0.0%)

Market Cap (In USD)

670.37 Thousand

Revenue (In USD)

45.36 Thousand

Net Income (In USD)

-7.43 Million

Avg. Volume

31.37 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.001-0.023
PE
-
EPS
-
Beta Value
-0.222
ISIN
CA19243C1005
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Dr. Sina Habibi
Employee Count
-
Website
https://www.cognetivity.com
Ipo Date
2021-01-08
Details
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

More Stocks